Alemtuzumab vs. Interferon Beta-1a in Early Multiple SclerosisNEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple SclerosisNEJM 376:221-234,280, Hauser, S.L.,et al, 2017